EPITHERAPEUTICS ApS: Financial statements 2013
CVR: 30523067
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -20,667,009 and a net result of DKK -34,462,624 compared with DKK -26,646,160 the year before. Equity in the 2013 report amounted to DKK 15,701,326. The solvency ratio was 54.6%.
- Gross Profit
- DKK -20,667,009
- Profit/Loss
- DKK -34,462,624
- Equity
- DKK 15,701,326
- Total Assets
- DKK 28,757,929
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -20.7 mio. | -34.5 mio. | 15.7 mio. | - |
| 2012 | - | -11.9 mio. | -26.6 mio. | -9.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of October 24, 2013, Georges Gemayel is registered as chairman of EPITHERAPEUTICS ApS.
As of October 24, 2013, Peter Høngård Andersen has stepped down as chairman of EPITHERAPEUTICS ApS.
EPITHERAPEUTICS ApS has published its annual report for 2012. Gross profit came to DKK -11,928,543, and the net result was DKK -26,646,160.
As of January 8, 2013, JUT NR. 2180 A/S has been appointed auditor of EPITHERAPEUTICS ApS.
As of January 8, 2013, EY Danmark A/S has stepped down as auditor of EPITHERAPEUTICS ApS.
About EPITHERAPEUTICS ApS
EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008. The company has been dissolved on 14 April 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2015). In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity in the 2021 report amounted to DKK 9,205,571.